Last updated on November 2017

Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

---

Brief description of study

Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

Detailed Study Description

Type 2 Diabetes? Currently using Insulin? Such as Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

You may be eligible to participate in a 58 week Research Study if you are:

• Diagnosed with Type 2 Diabetes
• Currently using insulin
• Age 18 or older

ClinicalTrials.gov Identifier: NCT03078478